Variant report

Variant	esv3526938
Chromosome Location	chr22:30114552-30117950
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:21)
CpG islands
(count:794)
Chromatin interactive
region (count:1)
LncRNA
region (count:5)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:21 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr22:30117117-30117164	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTCF	chr22:30114560-30114710	A549	lung:	n/a	n/a
3	CTCF	chr22:30114640-30114790	SK-N-SH_RA	brain:	n/a	n/a
4	CTCF	chr22:30114650-30114736	H1-hESC	embryonic stem cell:	n/a	n/a
5	CTCF	chr22:30114560-30114757	K562	blood:	n/a	n/a
6	CTCF	chr22:30114580-30114730	HEK293	kidney:	n/a	n/a
7	CTCF	chr22:30114580-30114730	K562	blood:	n/a	n/a
8	CTCF	chr22:30114620-30114770	HepG2	liver:	n/a	n/a
9	CTCF	chr22:30114693-30114717	MCF-7	breast:	n/a	n/a
10	CTCF	chr22:30114600-30114750	WERI-Rb-1	eye:	n/a	n/a
11	MAX	chr22:30115114-30115200	NB4	blood:	n/a	chr22:30115146-30115161 chr22:30115149-30115160
12	RAD21	chr22:30114575-30114784	HepG2	liver:	n/a	n/a
13	REST	chr22:30114792-30115577	SK-N-SH	brain:	n/a	chr22:30115462-30115475
14	REST	chr22:30115947-30116181	SK-N-SH	brain:	n/a	chr22:30116082-30116100
15	SIN3A	chr22:30116865-30116995	H1-hESC	embryonic stem cell:	n/a	chr22:30116972-30116985
16	SUZ12	chr22:30115076-30117639	NT2-D1	testis:	n/a	n/a
17	UBTF	chr22:30114706-30114778	K562	blood:	n/a	n/a
18	UBTF	chr22:30116004-30116146	K562	blood:	n/a	n/a
19	ZBTB7A	chr22:30116621-30117362	ECC-1	luminal epithelium:	n/a	chr22:30116638-30116649
20	ZBTB7A	chr22:30116593-30117503	ECC-1	luminal epithelium:	n/a	chr22:30116638-30116649
21	ZNF263	chr22:30117454-30117804	HEK293-T-REx	kidney:	n/a	n/a

(count:794 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr22:30116489-30116539	AG04450	lung:	fetal
2	chr22:30116489-30116539	AG04450	lung:	fetal
3	chr22:30115348-30115398	GM06990	blood:	n/a
4	chr22:30116439-30116489	SKMC	muscle:	n/a
5	chr22:30116489-30116539	K562	blood:	n/a
6	chr22:30116328-30116378	HL-60	blood:	n/a
7	chr22:30117148-30117198	BE2_C	brain:	n/a
8	chr22:30117148-30117198	NH-A	brain:	n/a
9	chr22:30115154-30115204	HEK293	kidney:	embryo
10	chr22:30116489-30116539	T-47D	breast:	n/a
11	chr22:30116319-30116369	NHBE	bronchial:	n/a
12	chr22:30116319-30116369	HEK293	kidney:	embryo
13	chr22:30117148-30117198	AG10803	skin:	n/a
14	chr22:30116319-30116369	GM19239	blood:	n/a
15	chr22:30117734-30117784	K562	blood:	n/a
16	chr22:30116439-30116489	GM12892	blood:	n/a
17	chr22:30116037-30116087	AG09309	skin:	n/a
18	chr22:30115203-30115253	AG04449	skin:	fetal
19	chr22:30116328-30116378	HepG2	liver:	n/a
20	chr22:30115348-30115398	H1-hESC	embryonic stem cell:	embryo
21	chr22:30117159-30117209	HRCEpiC	kidney:	n/a
22	chr22:30116919-30116969	Hepatocyte	liver:	n/a
23	chr22:30115154-30115204	HUVEC	blood vessel:	n/a
24	chr22:30116037-30116087	PrEC	prostate:	n/a
25	chr22:30116319-30116369	Hepatocyte	liver:	n/a
26	chr22:30117734-30117784	HL-60	blood:	n/a
27	chr22:30117159-30117209	PrEC	prostate:	n/a
28	chr22:30115348-30115398	MCF10A-Er-Src	breast:	n/a
29	chr22:30116328-30116378	Caco-2	colon:	n/a
30	chr22:30115203-30115253	AG09319	gingival:	n/a
31	chr22:30116489-30116539	GM12891	blood:	n/a
32	chr22:30116919-30116969	NH-A	brain:	n/a
33	chr22:30117148-30117198	T-47D	breast:	n/a
34	chr22:30117148-30117198	Caco-2	colon:	n/a
35	chr22:30115203-30115253	GM12891	blood:	n/a
36	chr22:30116489-30116539	HEK293	kidney:	embryo
37	chr22:30116953-30117003	ovcar-3	ovarian:	n/a
38	chr22:30116919-30116969	HepG2	liver:	n/a
39	chr22:30116489-30116539	HEEpiC	esophagus:	n/a
40	chr22:30116037-30116087	IMR90	lung:	fetal
41	chr22:30116919-30116969	GM12892	blood:	n/a
42	chr22:30117734-30117784	NH-A	brain:	n/a
43	chr22:30116328-30116378	HRE	kidney:	n/a
44	chr22:30116953-30117003	Caco-2	colon:	n/a
45	chr22:30116319-30116369	HCPEpiC	choroid plexus:	n/a
46	chr22:30115154-30115204	BE2_C	brain:	n/a
47	chr22:30117159-30117209	BE2_C	brain:	n/a
48	chr22:30116319-30116369	CMK	blood:	n/a
49	chr22:30116919-30116969	MCF10A-Er-Src	breast:	n/a
50	chr22:30116953-30117003	HEK293	kidney:	embryo

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr22:30117740..30119771-chr22:30165612..30167453,2	MCF-7	breast:

(count:5 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ZMAT5-1	chr22:30115558-30115703	XLOC_014338
2	lnc-ZMAT5-1	chr22:30114214-30114787	NONHSAT084729
3	lnc-ZMAT5-1	chr22:30115537-30115756	NONHSAT084729
4	lnc-ZMAT5-1	chr22:30115537-30115737	XLOC_014338
5	lnc-ZMAT5-1	chr22:30115537-30115848	XLOC_014338

No data

Variant related genes	Relation type
CABP7	TF binding region
ENSG00000232396	TF binding region
ENSG00000239446	TF binding region
CABP7	CpG island
ENSG00000232396	CpG island
ENSG00000239446	CpG island
NID1	miRNA target sites

Extended variants
information (count: 85 )
Associated
traits (count: 67 )

Variant overlapped rSNPs/rCNVs (count:85 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs555433707	chr22:30114602-30114603	Bivalent Enhancer Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
2	rs573806103	chr22:30114603-30114604	Bivalent Enhancer Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
3	rs372821188	chr22:30114617-30114618	Bivalent Enhancer Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
4	rs536938466	chr22:30114624-30114625	Bivalent Enhancer Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
5	rs73390966	chr22:30114675-30114676	Bivalent Enhancer Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs533046587	chr22:30114695-30114696	Bivalent Enhancer Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
7	rs9614034	chr22:30114699-30114700	Bivalent Enhancer Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
8	rs539203724	chr22:30114757-30114758	Bivalent Enhancer Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
9	rs77032875	chr22:30114770-30114771	Bivalent Enhancer Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
10	rs560217650	chr22:30114775-30114776	Bivalent Enhancer Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
11	rs116951931	chr22:30114784-30114785	Bivalent Enhancer Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
12	rs555796810	chr22:30114844-30114845	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs192457620	chr22:30114906-30114907	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs540861698	chr22:30114916-30114917	Bivalent Enhancer Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs8142249	chr22:30115025-30115026	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs531435150	chr22:30115132-30115133	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs549775490	chr22:30115175-30115176	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
18	rs576164936	chr22:30115186-30115187	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
19	rs571236289	chr22:30115217-30115218	Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
20	rs538288565	chr22:30115245-30115246	Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
21	rs558407397	chr22:30115379-30115380	Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
22	rs542048365	chr22:30115521-30115522	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs560504661	chr22:30115572-30115573	Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
24	rs534086895	chr22:30115653-30115654	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
25	rs574131110	chr22:30115656-30115657	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
26	rs183411929	chr22:30115667-30115668	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
27	rs556832719	chr22:30115678-30115679	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
28	rs188664302	chr22:30115762-30115763	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS Weak transcription	TF binding region lncRNA	3 gene(s)	Overlapped CNVs	n/a
29	rs573771279	chr22:30115781-30115782	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS Weak transcription	TF binding region lncRNA	3 gene(s)	Overlapped CNVs	n/a
30	rs59518516	chr22:30115796-30115797	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers Active TSS Weak transcription	TF binding region lncRNA	3 gene(s)	Overlapped CNVs	n/a
31	rs544317704	chr22:30115840-30115841	Bivalent/Poised TSS Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region lncRNA	3 gene(s)	Overlapped CNVs	n/a
32	rs556275166	chr22:30115899-30115900	Bivalent/Poised TSS Enhancers Bivalent Enhancer Active TSS Weak transcription	TF binding region	3 gene(s)	Overlapped CNVs	n/a
33	rs577950453	chr22:30116097-30116098	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs191509105	chr22:30116256-30116257	Bivalent/Poised TSS Enhancers Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs545117020	chr22:30116400-30116401	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs375700349	chr22:30116405-30116406	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs560383681	chr22:30116452-30116453	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
38	rs201946698	chr22:30116467-30116468	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
39	rs527598162	chr22:30116535-30116536	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
40	rs542794390	chr22:30116548-30116549	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
41	rs561088496	chr22:30116560-30116561	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
42	rs531400391	chr22:30116566-30116567	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
43	rs182614501	chr22:30116623-30116624	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
44	rs2527347	chr22:30116692-30116693	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs532126087	chr22:30116736-30116737	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
46	rs187136516	chr22:30116754-30116755	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
47	rs576690392	chr22:30116878-30116879	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Active TSS ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
48	rs534243487	chr22:30116879-30116880	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Active TSS ZNF genes & repeats	TF binding region	2 gene(s)	Overlapped CNVs	n/a
49	rs549134446	chr22:30116932-30116933	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Active TSS ZNF genes & repeats	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
50	rs572262889	chr22:30116968-30116969	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Active TSS ZNF genes & repeats	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:67)

Disease	PMID	Source
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Velocardiofacial syndrome	20111667	CNVD
Medulloblastoma	21979893	CNVD
sporadic solitary meningiomas	19589153	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Congenital heart defect	22511896	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Acute myeloid leukemia	16864856	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Seminomas	18059402	CNVD
Cancer	16751803	CNVD
Metanephric adenoma	20802469	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Colorectal cancer	19359472	CNVD
Metachromatic leukodystrophy	18421352	CNVD
Basal cell lymphoma	17170743	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Breast cancer	21858162	CNVD
Myelodysplastic syndrome	21251322	CNVD
Acute myeloid leukemia	20729466	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	16608533	CNVD
Melanoma	18172304	CNVD
Ovarian cancer	22174824	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Wilms tumour	21544195	CNVD
Acute myeloid leukemia	21251322	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Medullary thyroid carcinoma	18765511	CNVD
Lung cancer	18438408	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
small cell lung cancer	20016488	CNVD
Cancer	21183584	CNVD
Renal cell carcinoma	18765545	CNVD
Schizophrenia	19521646	CNVD
Schizophrenia	18990708	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Hepatocellular carcinoma	16750200	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Myelofibrosis	22110671	CNVD
Non-small cell lung cancer	21829676	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Autism	17322880	CNVD
Breast cancer	20409316	CNVD
Neurofibromatosis type 2	19566914	CNVD
Autism	19384346	CNVD
Melanoma	17363583	CNVD

Chromatin state (count:251 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr22:30098800-30115600	Weak transcription	Right Atrium	heart
2	chr22:30110600-30114800	Enhancers	Fetal Brain Male	brain
3	chr22:30111000-30114600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr22:30112800-30116600	Weak transcription	Pancreas	Pancrea
5	chr22:30113000-30115000	Weak transcription	Spleen	Spleen
6	chr22:30113600-30114600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
7	chr22:30113600-30114600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
8	chr22:30113600-30114600	Weak transcription	Fetal Brain Female	brain
9	chr22:30114000-30114600	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
10	chr22:30114400-30115800	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
11	chr22:30114600-30114800	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
12	chr22:30114600-30115000	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
13	chr22:30114600-30115000	Enhancers	Fetal Brain Female	brain
14	chr22:30114800-30115200	Bivalent Enhancer	Brain Germinal Matrix	brain
15	chr22:30114800-30115400	Bivalent Enhancer	Fetal Brain Male	brain
16	chr22:30114800-30115600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
17	chr22:30114800-30115600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
18	chr22:30114800-30115800	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
19	chr22:30114800-30115800	Bivalent Enhancer	Right Ventricle	heart
20	chr22:30114800-30115800	Enhancers	A549	lung
21	chr22:30115000-30115200	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
22	chr22:30115000-30115600	Flanking Active TSS	Fetal Brain Female	brain
23	chr22:30115000-30115800	Enhancers	Gastric	stomach
24	chr22:30115000-30116200	Bivalent Enhancer	Spleen	Spleen
25	chr22:30115200-30115600	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
26	chr22:30115200-30115600	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr22:30115200-30115600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
28	chr22:30115200-30115600	Bivalent Enhancer	HepG2	liver
29	chr22:30115200-30115800	Bivalent Enhancer	Colon Smooth Muscle	Colon
30	chr22:30115200-30115800	Bivalent Enhancer	Esophagus	oesophagus
31	chr22:30115200-30116000	Bivalent Enhancer	Primary B cells from peripheral blood	blood
32	chr22:30115200-30116000	Bivalent Enhancer	Sigmoid Colon	Sigmoid Colon
33	chr22:30115400-30115600	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
34	chr22:30115400-30115600	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
35	chr22:30115400-30115600	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
36	chr22:30115400-30115600	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
37	chr22:30115400-30115600	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
38	chr22:30115400-30115600	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
39	chr22:30115400-30115600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
40	chr22:30115400-30115600	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
41	chr22:30115400-30115800	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
42	chr22:30115400-30115800	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
43	chr22:30115400-30115800	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
44	chr22:30115400-30115800	Bivalent Enhancer	Primary T cells effector/memory enriched fromperipheralblood	blood
45	chr22:30115400-30115800	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
46	chr22:30115400-30115800	Bivalent Enhancer	Brain Germinal Matrix	brain
47	chr22:30115400-30115800	Bivalent Enhancer	Brain Inferior Temporal Lobe	brain
48	chr22:30115400-30115800	Enhancers	Fetal Brain Male	brain
49	chr22:30115400-30115800	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
50	chr22:30115400-30115800	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links